Programmed death-1 blockade with pembrolizumab in patients with classical hodgkin lymphoma after brentuximab vedotin failure

Philippe Armand, Margaret A. Shipp, Vincent Ribrag, Jean Marie Michot, Pier Luigi Zinzani, John Kuruvilla, Ellen S. Snyder, Alejandro D. Ricart, Arun Balakumaran, Shelonitda Rose, Craig H. Moskowitz

Research output: Contribution to journalArticlepeer-review

412 Scopus citations

Fingerprint

Dive into the research topics of 'Programmed death-1 blockade with pembrolizumab in patients with classical hodgkin lymphoma after brentuximab vedotin failure'. Together they form a unique fingerprint.

Medicine & Life Sciences